SkinHealth Systems (SKIN) Short term Debt (2025 - 2026)
SkinHealth Systems' (SKIN) quarterly Short term Debt came in at $103.1 million in Q2 2026, little changed quarter-over-quarter from $102.9 million in Q1 2026.
Powered by 
Analysis
SkinHealth Systems (SKIN) Short term Debt (2025 - 2026) Analysis & Trends
SkinHealth Systems (SKIN) has reported Short term Debt for 2 consecutive years, with $103.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Short term Debt changed N/A year-over-year to $103.1 million in Q2 2026; TTM through Jun 2026 was $103.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $124.0 million, changed N/A from the prior year.
- Short term Debt was $103.1 million for Q2 2026 at SkinHealth Systems, roughly flat from $102.9 million in the prior quarter.
- Over five years, Short term Debt peaked at $124.0 million in Q4 2025 and troughed at $102.9 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.61 Bn | 179.00 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 126.43 Bn | 121.22 Bn | 1.96 Bn |
| 3 | Medtronic | 119.26 Bn | 110.45 Bn | 6.34 Bn |
| 4 | Stryker | 106.19 Bn | 102.71 Bn | 4.50 Bn |
| 5 | Boston Scientific | 67.54 Bn | 67.00 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 50.12 Bn | 45.87 Bn | 1.35 Bn |
| 7 | Alcon | 34.19 Bn | 32.73 Bn | 1.68 Bn |
| 8 | Dexcom | 31.88 Bn | 29.94 Bn | 830.00 Mn |
| 9 | Steris | 21.21 Bn | 20.73 Bn | 684.20 Mn |
| 10 | SkinHealth Systems | 92.21 Mn | -113.87 Mn | 49.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 103.09 Mn |
| Mar 31, 2026 | 102.94 Mn |
| Dec 31, 2025 | 123.96 Mn |